Quantitative structure - activity relationship studies on membrane receptors inhibition by antipsychotic drugs. Application to schizophrenia treatment

被引:16
作者
Avram, Speranta [1 ]
Berner, Heinz
Milac, Adina L. [3 ]
Wolschann, Peter [2 ]
机构
[1] Univ Bucharest, Fac Biol, Dept Physiol & Biophys, Bucharest 76201, Romania
[2] Univ Vienna, Inst Theoret Chem, Vienna, Austria
[3] Romanian Acad, Inst Biochem, Bucharest, Romania
来源
MONATSHEFTE FUR CHEMIE | 2008年 / 139卷 / 04期
关键词
antipsychotics; 2D-QSAR; membrane receptors;
D O I
10.1007/s00706-007-0782-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
There are presented six new QSAR models, which are correlating antipsychotic activity ( pK(i) values at dopamine D1 - D4 and serotonine ( 5- HT2C, 5- HT2A) receptors) with physicochemical parameters. A large data set of typical and atypical antipsychotics already approved for clinical treatment including as well representatives with new chemical structures which are exhibiting antipsychotic activity ( tetrahydrofuran-, benzamide-, 3- aminoethyl- 1- tetralones, piperazine-, benzothiazepine- and pyrrolobenzazepinederivatives) were incorporated within this study. The appropriate 2D and internal- 3D molecular descriptors could be generated by use of the computational software MOE ( Molecular Operating Environment). Significant q(2) ( 0.63 - 0.76) and r(2) ( 0.70 - 0.78) correlation coefficients were obtained, indicating that the established equations can be used within a wide range of binding constants ( pK(i) 5 to 9.76). By use of these linear models an assembly of new aripiprazole structures could be established. Some of them are showing significantly improved antipsychotic activity in comparison with the parent compound.
引用
收藏
页码:407 / 426
页数:20
相关论文
共 63 条
[41]   Schizophrenia [J].
Mueser, KT ;
McGurk, SR .
LANCET, 2004, 363 (9426) :2063-2072
[42]   Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor [J].
Neve, KA ;
Cumbay, MG ;
Thompson, KR ;
Yang, R ;
Buck, DC ;
Watts, VJ ;
Durand, CJ ;
Teeter, MM .
MOLECULAR PHARMACOLOGY, 2001, 60 (02) :373-381
[43]   GRID/GOLPE 3D quantitative structure-activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D-3 receptor subtype [J].
Nilsson, J ;
Wikstrom, H ;
Smilde, A ;
Glase, S ;
Pugsley, T ;
Cruciani, G ;
Pastor, M ;
Clementi, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :833-840
[44]   Positron emission tomography finding of a high striatal D2 receptor occupancy in olanzapine-treated patients [J].
Nordström, AL ;
Nyberg, S ;
Olsson, H ;
Farde, L .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (03) :283-284
[45]   APPLICATIONS OF THE RADIUS DIAMETER DIAGRAM TO THE CLASSIFICATION OF TOPOLOGICAL AND GEOMETRICAL SHAPES OF CHEMICAL-COMPOUNDS [J].
PETITJEAN, M .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1992, 32 (04) :331-337
[46]   Conformationally constrained butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2A, 5-HT2C) affinities:: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics [J].
Raviña, E ;
Negreira, J ;
Cid, J ;
Masaguer, CP ;
Rosa, E ;
Rivas, ME ;
Fontenla, JA ;
Loza, MI ;
Tristán, H ;
Cadavid, MI ;
Sanz, F ;
Lozoya, E ;
Carotti, A ;
Carrieri, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2774-2797
[47]   NEUROLEPTIC BINDING TO HUMAN-BRAIN RECEPTORS - RELATION TO CLINICAL EFFECTS [J].
RICHELSON, E .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 537 :435-442
[48]   QSAR studies in substituted 1,2,3,4,6,7,12,12a-octa-hydropyrazino[2′,1′:6,1]pyrido[3,4-b]indoles -: A potent class of neuroleptics [J].
Saxena, AK ;
Ram, S ;
Saxena, M ;
Singh, N ;
Prathipati, P ;
Jain, PC ;
Singh, HK ;
Anand, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (09) :2085-2090
[49]   Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors [J].
Seeman, P ;
Tallerico, T .
MOLECULAR PSYCHIATRY, 1998, 3 (02) :123-134
[50]   Antipsychotic drugs, dopamine receptors, and schizophrenia [J].
Seeman, P .
CLINICAL NEUROSCIENCE RESEARCH, 2001, 1 (1-2) :53-60